• Return to Headlines

Neogenomics Inc Up 36.3% Since SmarTrend Uptrend Call (NEO)

By Amy Schwartz

SmarTrend identified an Uptrend for Neogenomics Inc (NASDAQ:NEO) on February 22nd, 2018 at $8.26. In approximately 3 months, Neogenomics Inc has returned 36.28% as of today's recent price of $11.25.

In the past 52 weeks, Neogenomics Inc share prices have been bracketed by a low of $6.90 and a high of $11.63 and are now at $11.24, 63% above that low price. Over the past week, the 200-day moving average (MA) has gone up 0.4% while the 50-day MA has advanced 2.4%.

NeoGenomics, Inc. operates a network of clinical laboratories that specializes in cancer genetics diagnostic testing services. The Company's services include cytogenetics, fluorescence in-situhybridization (FISH), flow cytometry, morphology, anatomic pathology, and molecular genetic testing. NeoGenomics serves pathologists, oncologists, urologists, and hospitals.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Neogenomics Inc shares.

Log in and add Neogenomics Inc (NEO) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights neogenomics inc

Ticker(s): NEO